Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Tuberculosis: what we don't know can, and does, hurt us.

Russell DG, Barry CE 3rd, Flynn JL.

Science. 2010 May 14;328(5980):852-6. doi: 10.1126/science.1184784. Review.

2.

Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.

Dietrich J, Doherty TM.

APMIS. 2009 May;117(5-6):440-57. doi: 10.1111/j.1600-0463.2009.02458.x. Review.

PMID:
19400867
4.

Host-pathogen interactions in latent Mycobacterium tuberculosis infection: identification of new targets for tuberculosis intervention.

Lin MY, Ottenhoff TH.

Endocr Metab Immune Disord Drug Targets. 2008 Mar;8(1):15-29. Review.

PMID:
18393920
5.

Mycobacterium tuberculosis metabolism.

Warner DF.

Cold Spring Harb Perspect Med. 2014 Dec 11;5(4). pii: a021121. doi: 10.1101/cshperspect.a021121. Review.

PMID:
25502746
6.

The impact of transcriptomics on the fight against tuberculosis: focus on biomarkers, BCG vaccination, and immunotherapy.

Zárate-Bladés CR, Silva CL, Passos GA.

Clin Dev Immunol. 2011;2011:192630. doi: 10.1155/2011/192630. Epub 2010 Dec 20. Review.

7.

The challenge of new drug discovery for tuberculosis.

Koul A, Arnoult E, Lounis N, Guillemont J, Andries K.

Nature. 2011 Jan 27;469(7331):483-90. doi: 10.1038/nature09657. Review.

PMID:
21270886
8.

Vaccination against tuberculosis: how can we better BCG?

Pitt JM, Blankley S, McShane H, O'Garra A.

Microb Pathog. 2013 May;58:2-16. doi: 10.1016/j.micpath.2012.12.002. Epub 2012 Dec 17. Review.

PMID:
23257069
9.

Development of new vaccines and drugs for TB: limitations and potential strategic errors.

Orme IM.

Future Microbiol. 2011 Feb;6(2):161-77. doi: 10.2217/fmb.10.168. Review.

10.

Strategies for developing tuberculosis vaccines: emerging approaches.

Mollica A, Stefanucci A, Costante R.

Curr Drug Targets. 2013 Aug;14(9):938-51. Review.

PMID:
23469877
11.

Immunological requirements for a subunit vaccine against tuberculosis.

Elhay MJ, Andersen P.

Immunol Cell Biol. 1997 Dec;75(6):595-603. Review.

12.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
13.

A case for a neonatal, low-dose BCG vaccination trial.

Bretscher P, Menon J, Power C, Uzonna J, Wei G.

Scand J Infect Dis. 2001;33(4):253-7. Review.

PMID:
11345215
14.

Tuberculosis vaccine development: recent progress.

Orme IM, McMurray DN, Belisle JT.

Trends Microbiol. 2001 Mar;9(3):115-8. Review.

PMID:
11239788
15.

TB drug development: immunology at the table.

Nathan C, Barry CE 3rd.

Immunol Rev. 2015 Mar;264(1):308-18. doi: 10.1111/imr.12275. Review.

16.

Tuberculosis vaccines: hopes and hurdles.

Ahsan MJ, Garg SK, Vashistha B, Sharma P.

Infect Disord Drug Targets. 2013 Oct;13(5):318-21. Review.

PMID:
24304353
17.

Cytokine and lipid mediator networks in tuberculosis.

Mayer-Barber KD, Sher A.

Immunol Rev. 2015 Mar;264(1):264-75. doi: 10.1111/imr.12249. Review.

18.

Immunological biomarkers of tuberculosis.

Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A.

Nat Rev Immunol. 2011 May;11(5):343-54. doi: 10.1038/nri2960. Epub 2011 Apr 8. Review.

PMID:
21475309
19.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
20.

Tuberculosis vaccine research: the impact of immunology.

Barker LF, Brennan MJ, Rosenstein PK, Sadoff JC.

Curr Opin Immunol. 2009 Jun;21(3):331-8. doi: 10.1016/j.coi.2009.05.017. Epub 2009 Jun 7. Review.

PMID:
19505813
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk